2 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
in HF and CKD. ... HF outcomes in HFrEF ... HF outcomes in HFrEF ... #inhibitors #EBM ... #CVD #CKD
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
Guideline-Directed ... ) in HFrEF and CKD ... diuretics, MRA, SGLT2i ... Statins, Thiazides ... #CKD #HFrEF #management